Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05562960
NA
Plasmapheresis in Amyotrophic Lateral Sclerosis With Autoantibody Against NRIP
Sponsor: National Taiwan University Hospital
View on ClinicalTrials.gov
Summary
Patient with amyotrophic lateral sclerosis (ALS) having anti-NRIP autoantibody showed titer-dependent detrimental Effects. Plasmapheresis might benefit this subgroup of patients via removal of anti-NRIP autoantibody
Key Details
Gender
All
Age Range
20 Years - Any
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2023-05-01
Completion Date
2025-03-31
Last Updated
2024-12-18
Healthy Volunteers
No
Interventions
PROCEDURE
Plasmapheresis
Regular plasmapheresis to remove anti-NRIP autoantibody
Locations (1)
National Taiwan University Hospital
Taipei, Taiwan